Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin and Noradrenaline in Hepatorenal Syndrome Type 1
NCT03822091Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of norepinephrine in hepatorenal syndrome type 1 (HRS-1), sponsored by Post Graduate Institute of Medical Education and Research. Started Jan 2019; status: completed.
02
Drugs
norepinephrine
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT03822091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822091.